Latest filing published 31 Mar 2026 for Dr. Lal Path Labs Ltd., €12k.
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Rahul Sharma in Dr. Lal Path Labs Ltd., where the filings describe the role as senior executive. Between 6 May 2022 and 30 March 2026, the trades on record add up to 41 filings.
The open-market record consists of 27 sales worth €2.5M, with no purchase. Outside the open market, there are 14 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 31 March 2026 with an open-market sale (€12k) in Dr. Lal Path Labs Ltd. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations